z-logo
open-access-imgOpen Access
Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism
Author(s) -
Noriko Sato,
Ryu Matsuo,
Fumi Kiyuna,
Kuniyuki Nakamura,
Jun Hata,
Yoshinobu Wakisaka,
Tetsuro Ago,
Masahiro Kamouchi,
Takanari Kitazono
Publication year - 2020
Publication title -
cerebrovascular diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.221
H-Index - 104
eISSN - 1421-9786
pISSN - 1015-9770
DOI - 10.1159/000510773
Subject(s) - medicine , embolic stroke , stroke (engine) , embolism , intracranial embolism , cardiology , stroke risk , ischemic stroke , ischemia , mechanical engineering , engineering
This study aimed to determine whether use of oral anticoagulants (OACs) was associated with a reduced risk of recurrent stroke compared with use of antiplatelets (APs) in patients with embolic stroke of undetermined source (ESUS) having no potential source of embolism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom